Wehave previously reported on the preparation and initial characterization of the structure and biological activity of siamycins I and II1}. Here, we report on the novel strategy used to rapidly determine the primary, secondary and preliminary solution structure of siamycin I using a multidisciplinary approach that utilized primarily MSand NMRdata. The presence of three internal covalent cross-linkages found in siamycin I made structure analysis by traditional methods difficult, particularly in the TV-terminal region.
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Lowresolution full scan and product ion mass spectra were acquired on a Sciex API /// tandem quadrupole mass spectrometer equipped with an Ionspray (pneumatically assisted electrospray) interface. Samples were analyzed in the flow injection mode using a 0.1% trifluoroacetic acid in methanol mobile phase at a flow rate of 60/d/minute. The ionspray tip was operated at +5300V. Full scan mass spectra were obtained using an orifice voltage of 75 eV while scanning from m/z 800 to 2250 with a step size of 0.4D and a dwell time of 1.5msec. Product ion spectra were obtained from collision induced dissociation (CID) with an argon collision gas at 450x 1012atoms/cm2 and a collision energy of 65 eV. NMRdata were collected on a Varian Unity 500 spectrometer and processed on a Silicon
Graphics Crimson workstation using Felix (Biosym).
Spectra were collected on a 3.5mMsample of siamycin I in 99% DMSO-J6. Double quantum filtered COSY spectra (DQF-COSY)2), 2D total correlation spectra (TOCSY)3) and NOESY4) two-dimensional XH NMR datasets were collected with 512 tx values and 2K complex t2 data points using the hyercomplex method for frequency discrimination in col 5 a Tanabe Seiyaku Co., Ltd. 2-2-50 Kawagishi, Toda, Saitama 335, Japan.
b Biotechnology Research Center, Toyama Prefectural University, Kosugi, Toyama 939-03, Japan. 2 Asx) plus F10. The NOESYspectrum of intact siamycin I was re-examined with these data and a Leu-Gly-Val-Gly fragment was detected based on clear sequential connectivities between these unique spin systems (TVterminus contains LGVG sequence). The Leu residue had one AMX spin system on its Af-terminus and the C-terminal Gly was sequentially connected to four AMX residues with the fourth connected to Phe-10 (Nterminus= XI L2 G3 V4 G5 X6 X7 X8 X9 F10). X8
was identified as an Asn based on NOEcrosspeaks between the H^of this AMX spin system and two non-backbone amide protons (Af-terminus=Xl L2 G3 V4 G5 X6X7 N8 X9 F10). Based on the lack of MS/MS fragmentation beyond Phe-10 (stability of the product ion at m/z 919 in Fig. 1A ) coupled with problems encountered with Edmandegradation of this proteolytic fragment, cyclization was inferred at X9. A more detailed examination of the NOESYdata on native siamycin I revealed NOEcrosspeaks between the backbone amide proton of the XI and the H^protons of the X9 (Fig.  IB) . This bond could not be a sequential linkage since L2 was already sequentially linked to XI and G3 while the X9 was sequentially linked N8 and F10. These observations suggested the presence an amide bond between the backbone amide nitrogen of the XI and the sidechain ofX9 suggesting that the ninth residue was an aspartate to accommodatesuch a linkage. The remaining residues (3 AMXs)were resolved based on an analysis of the chemical shifts of the H^protons (Ser H^protons are shifted down field with respect to other H^protons)7)
resulting in the determination of the N-terminal 9 residues to Cysl Leu2 Gly3 Val4 Gly5 Ser6 Cys7 Asn8 Asp9 with an amide linkage between Cl backbone nitrogen and D9 side-chain carboxyl.
Combining the previous analysis, additional secondary structural information in the form of disulflde linkages was suggested by the MSdata on native siamycin I. A knowledge of the sequence and iV-terminal cyclization, suggested the presence of two disulfide bonds based on DEC. 1995 the observed molecular weight of native siamycin I. Again, a re-examination of the NOESY data suggested the presence of a disulfide linkage between Cl and C13 based on NOEs between the Ha of Cys-1 and the Hp rotons of Cys-13. The remaining disulfide bond was assigned to Cys-7 and Cys-19. These data, along with the sequential and other secondary structure information, were combined in structural calculations and an ensemble of ten structures was computed based on the quantified NOEdata using DG-II. No violations in excess of 0.1 A were observed in any of the structures. Fig. 2 shows a superimposition of five from the ensemble of 10 structures. The average RMSD of the backbone atoms for the five structures shown is 1.83A using the structure with the lowest residual error from the DG-II calculations as the fixed structure. The backbone fold shows no evidence of regular secondary structure but rather consists of a series of extended stretches and turns. However, siamycin I is highly structured in solution and is closely similar to another syncitia inhibitory peptide RP71955 having Ile-4 and Val-178).
